¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Core Binding Factor alpha Subunits"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
dermonecrotic factor
ÇǺα«»çÀÎÀÚ
diabetogenic factor
´ç´¢º´À¯¹ßÀÎÀÚ
decay accelerating factor
ºØ±«ÃËÁøÀÎÀÚ
dilution factor
Èñ¼®ÀÎÀÚ
exclusion of confounding factor
±³¶õ¹èÁ¦ÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇÇÀ¯·¡¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇÇÀ¯·¡ÀÌ¿ÏÀÎÀÚ
endurance factor
°ßµõÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
fermentation factor
¹ßÈ¿ÀÎÀÚ
fertility factor
¼öÅÂÀÎÀÚ
fibrin stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
drug resistance factor
¾àÁ¦ÀúÇ×ÀÎÀÚ
elongation factor
´ÃÀÓÀÎÀÚ, ¿¬ÀåÀÎÀÚ
endothelium-derived contracting factor
³»ÇǼ¼Æ÷¼öÃàÀÎÀÚ
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷ÀÌ¿ÏÀÎÀÚ
endurance factor
Áö¼ÓÀÎÀÚ
eosinophil chemotactic factor
È£»ê±¸ÈÇÐÁÖ¼ºÀÎÀÚ, È£»ê±¸ÈÇнò¸²ÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
exogenous factor
¿ÜÀοä¼Ò
extrinsic factor
¿ÜÀÎÀÎÀÚ, ¿ÜÀÎÀÚ
factor
ÀÎÀÚ, ¿äÀÎ, °è¼ö
factor theory
¿äÀÎÀÌ·Ð
fermentation factor
¹ßÈ¿ÀÎÀÚ
fertility factor
¼öÅÂÀÎÀÚ
fibrin stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷¼ºÀåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
alpha-naphthyl acetate esterase
¾ËÆÄ-³ªÇÁÆ¿¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl acetate esterase =ANAE
¾ËÆÄ¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl butyrate esterase
¾ËÆÄ-³ªÇÁÆ¿ ºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthyl butyrate esterase =ANBE
¾ËÆÄºÎƼ·¹ÀÌÆ®¿¡½ºÅ×¶óÁ¦
alpha-naphthylamine
¾ËÆÄ-³ªÇÁÆ¿¾Æ¹Î
alpha-sympathomimetic agent
¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
alpha-thalassemia trait
¾ËÆÄ-Å»¶ó¼¼¹Ì¾Æ ¼ÒÀÎ
alpha/beta (¥á/¥â) ratio
¥á/¥â ºñ
galactosidase, alpha-galactosidase a, deficiency
#NAME?
glucosidase, alpha -1,4-glucosidase
-1,4-±Û·çÄڽõ¥À̽º
glucosidase, alpha-glucosidase(acid maltase)
-±Û·çÄڽõ¥À̽º, -glucosidase
inter-alpha-trypsin inhibitor
ÀÎÅÍ-¾ËÆÄ-Æ®¸³½Å ¾ïÁ¦Á¦
reductase, 5-alpha-reductase inhibitor
5a-ȯ¿øÈ¿¼Ò¾ïÁ¦Á¦(¡ü½êªý£áÈåäð¤ð¥),5a-¸®´öÅ×À̽º¾ïÁ¦Á¦(¡åäð¤ð¥)
AHF=£¾antihemophilic factor
Ç×Ç÷¿ìÀÎÀÚ.
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
unsaturated iron binding capacity
ºÒÆ÷Èö°áÇÕ´É(¡ôÑÌ¿ùêÒö).
unsaturated iron binding capacity
ºÒÆ÷Èö°áÇÕ´É
unsaturated vitamin B12 binding capacity
ºÒÆ÷ȺñŸ¹Î B12 °áÇÕ´É
alpha (¥á) chain
¾ËÆÄ»ç½½, ¾ËÆÄ¼â
alpha (¥á) chain disease
¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
alpha (¥á) globulin
¾ËÆÄ±Û·ÎºÒ¸°
alpha (¥á)-interferon
¾ËÆÄÀÎÅÍÆä·Ð
alpha amylase
¾ËÆÄ¾Æ¹Ð¶ó¾ÆÁ¦.
alpha angle
¾ËÆÄ°¢.
alpha antitrypsin deficiency panniculitis
¾ËÆÄ Çׯ®¸³½Å°áÇÌÁö¹æÃþ¿°
alpha behavior
¾ËÆÄÇàÀ§
alpha blocking
¾ËÆÄÂ÷´Ü
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½